Trials / Unknown
UnknownNCT05314842
Pulpotomy in Primary Molars Treated With Premixed Bio-ceramic MTA Versus Formocresol
Clinical and Radiographic Evaluation of Pulpotomy in Primary Molars Treated With Premixed Bio-ceramic MTA Versus Formocresol Among a Group of Egyptian Children: A Pilot Study.
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Sarah Abdelbar Mahmoud · Academic / Other
- Sex
- All
- Age
- 4 Years – 6 Years
- Healthy volunteers
- Accepted
Summary
examine the results of pulpotomy in primary molars using premixed bioceramic MTA versus Formocresol. Clinical and radiographic success rates were used as outcomes.
Detailed description
Primary outcome: Soft-tissue pathology * Post-treatment swelling will be assessed through visual examination by the operator, either intraorally or extra orally. * Sinus tract or fistula will be assessed through visual examination by the operator Secondary outcomes: 1. Pain to the percussion will be assessed by gentle tapping on the tooth with the end of a dental mirror 2. mobility will be assessed through the back of two mirrors 3. radiographic assessments:- for any radiolucency and pathologic root resorption (periapical or bifurcation) will be examined (present or not). clinical assessment on every recall visit during the 3-, 6-, and 12-month follow-up period. • These radiographic assessments will be performed as baseline data at the first visit following the operating procedure, as well as at 3, 6, and 12 months after the baseline.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Formocresol | dressing agents in pulpotomized primary molas using formocresol in cariously exposed vital primary molars |
| DRUG | Premixed bioceramic MTA | dressing agents in pulpotomized primary molas using premixed bioceramic MTA in cariously exposed vital primary molars |
Timeline
- Start date
- 2022-04-01
- Primary completion
- 2023-04-01
- Completion
- 2023-05-01
- First posted
- 2022-04-06
- Last updated
- 2022-04-06
Source: ClinicalTrials.gov record NCT05314842. Inclusion in this directory is not an endorsement.